PBE vs AQLT
Comparison between INVESCO BIOTECHNOLOGY & GENOME ETF (PBE, ETF) and ISHARES MSCI GLOBAL QUALITY FACTOR ETF (AQLT, ETF).
PBE vs AQLT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
Winner
PBE
$259M
AQLT
$259M
Expense Ratio
PBE
0.58%
Winner
AQLT
0.20%
Max Drawdown
PBE
45.69%
Winner
AQLT
16.84%
Sharpe Ratio
PBE
1.35
Winner
AQLT
1.40
5Y Beta
Winner
PBE
0.76
AQLT
0.91
P/E Ratio
PBE
36.34
Winner
AQLT
30.76
Forward P/E
Winner
PBE
19.88
AQLT
25.43
PEG Ratio
PBE
N/A
AQLT
0.74
5Y Dividends CAGR
PBE
98.81%
AQLT
N/A
5Y EPS CAGR
PBE
12.51%
Winner
AQLT
26.29%
Debt to Equity
PBE
54.69%
Winner
AQLT
48.59%
P/S Ratio
Winner
PBE
5.10
AQLT
5.82
P/B Ratio
Winner
PBE
4.58
AQLT
10.71
PBE vs AQLT - Holdings Comparison
PBE and AQLT have 3 common holdings. Overlap is -2.94%
PBE's top 25 holdings weight is 89.66%. AQLT's top 25 holdings weight is 59.77%.
| Rank | PBE | AQLT |
|---|---|---|
| #1 | ILLUMINA INC (ILMN) - 6.77% | BROADCOM INC (AVGO) - 5.41% |
| #2 | UNITED THERAPEUTICS CORP (UTHR) - 5.84% | MICROSOFT CORP (MSFT) - 5.35% |
| #3 | BIOGEN INC (BIIB) - 4.95% | n/a (n/a) - 5.23% |
| #4 | INCYTE CORP (INCY) - 4.67% | APPLE INC (AAPL) - 4.96% |
| #5 | GILEAD SCIENCES INC (GILD) - 4.42% | NVIDIA CORP (NVDA) - 4.93% |
| #6 | ALNYLAM PHARMACEUTICALS INC (ALNY) - 4.39% | META PLATFORMS INC CLASS A (META) - 4.27% |
| #7 | AMGEN INC (AMGN) - 4.38% | ELI LILLY AND CO (LLY) - 2.72% |
| #8 | REGENERON PHARMACEUTICALS INC (REGN) - 4.00% | ALPHABET INC CLASS A (GOOGL) - 2.63% |
| #9 | VERACYTE INC (VCYT) - 3.74% | ASML HOLDING NV (n/a) - 2.41% |
| #10 | CATALYST PHARMACEUTICALS INC (CPRX) - 3.61% | ALPHABET INC CLASS C (GOOG) - 2.07% |
| #11 | TG THERAPEUTICS INC (TGTX) - 3.35% | VISA INC CLASS A (V) - 1.98% |
| #12 | ROYALTY PHARMA PLC CLASS A (RPRX) - 3.32% | TWD CASH (n/a) - 1.62% |
| #13 | NEUROCRINE BIOSCIENCES INC (NBIX) - 3.30% | JOHNSON & JOHNSON (JNJ) - 1.55% |
| #14 | CAREDX INC (CDNA) - 3.20% | TWD/USD PURCHASED (n/a) - 1.48% |
| #15 | ARROWHEAD PHARMACEUTICALS INC (ARWR) - 3.10% | LAM RESEARCH CORP (LRCX) - 1.47% |
| #16 | BIOCRYST PHARMACEUTICALS INC (BCRX) - 3.06% | WALMART INC (WMT) - 1.32% |
| #17 | EXELIXIS INC (EXEL) - 3.00% | NETFLIX INC (NFLX) - 1.31% |
| #18 | PROTAGONIST THERAPEUTICS INC (PTGX) - 2.98% | APPLIED MATERIALS INC (AMAT) - 1.29% |
| #19 | PTC THERAPEUTICS INC (PTCT) - 2.76% | CISCO SYSTEMS INC (CSCO) - 1.27% |
| #20 | HALOZYME THERAPEUTICS INC (HALO) - 2.63% | COSTCO WHOLESALE CORP (COST) - 1.26% |
| #21 | VERICEL CORP (VCEL) - 2.51% | MASTERCARD INC CLASS A (MA) - 1.15% |
| #22 | REPLIGEN CORP (RGEN) - 2.51% | CATERPILLAR INC (CAT) - 1.14% |
| #23 | BIO-TECHNE CORP (TECH) - 2.41% | ROCHE HOLDING AG ORDINARY SHARES NEW (n/a) - 1.01% |
| #24 | IONIS PHARMACEUTICALS INC (IONS) - 2.38% | MERCK & CO INC (MRK) - 0.97% |
| #25 | BIOMARIN PHARMACEUTICAL INC (BMRN) - 2.38% | COCA-COLA CO (KO) - 0.97% |
| Total Holdings | 33 | 552 |
PBE vs AQLT - Historical Returns
Returns include dividend reinvestment.
1M
Winner
PBE
+1.34%
AQLT
+0.93%
3M
Winner
PBE
+10.51%
AQLT
+10.43%
6M
PBE
+5.02%
Winner
AQLT
+11.45%
1Y
Winner
PBE
+31.39%
AQLT
+24.57%
5Y(CAGR)
PBE
+1.98%
AQLT
N/A
10Y(CAGR)
PBE
+8.47%
AQLT
N/A
Max(CAGR)
PBE
+8.90%
Winner
AQLT
+16.92%
PBE vs AQLT - Annual Returns (2005 - 2026)
Returns include dividend reinvestment.
| Year | PBE | AQLT |
|---|---|---|
| 2026 | +2.24% | +10.09% |
| 2025 | +23.76% | +18.13% |
| 2024 | -0.05% | -3.14% |
| 2023 | +4.60% | N/A |
| 2022 | -11.11% | N/A |
| 2021 | +1.21% | N/A |
| 2020 | +25.68% | N/A |
| 2019 | +18.35% | N/A |
| 2018 | -2.62% | N/A |
| 2017 | +20.54% | N/A |
| 2016 | -20.66% | N/A |
| 2015 | +1.36% | N/A |
| 2014 | +36.45% | N/A |
| 2013 | +57.53% | N/A |
| 2012 | +13.17% | N/A |
| 2011 | -7.24% | N/A |
| 2010 | +29.99% | N/A |
| 2009 | +19.16% | N/A |
| 2008 | -25.84% | N/A |
| 2007 | +6.24% | N/A |
| 2006 | +0.45% | N/A |
| 2005 | +17.45% | N/A |
PBE vs AQLT Drawdown Comparison
The maximum drawdown for PBE was -45.69%, occurring on Mar 9, 2009. Recovery took 644 trading sessions.
The maximum drawdown for AQLT was -16.84%, occurring on Apr 8, 2025. Recovery took 91 trading sessions.
The current PBE drawdown is -1.80%. The current AQLT drawdown is -1.70%.
| Rank | PBE | AQLT |
|---|---|---|
| #1 | -45.69% Oct 15, 2007 - May 6, 2010 | -16.84% Feb 13, 2025 - Jun 26, 2025 |
| #2 | -44.56% Jul 17, 2015 - Jul 20, 2020 | -10.68% Feb 25, 2026 - Apr 17, 2026 |
| #3 | -37.84% Feb 8, 2021 - Nov 26, 2025 | -4.69% Oct 28, 2025 - Nov 28, 2025 |
| #4 | -35.71% May 6, 2010 - Apr 2, 2013 | -4.17% Dec 12, 2024 - Jan 23, 2025 |
| #5 | -21.12% Feb 27, 2006 - Apr 23, 2007 | -3.98% Jun 2, 2026 - Jun 10, 2026 |
| #6 | -18.86% Feb 24, 2014 - Aug 25, 2014 | -2.82% Oct 8, 2025 - Oct 20, 2025 |
| #7 | -14.38% Jul 20, 2020 - Nov 27, 2020 | -2.82% Jul 25, 2025 - Aug 12, 2025 |
| #8 | -11.73% Jan 7, 2026 - Mar 27, 2026 | -2.25% Jan 29, 2026 - Feb 9, 2026 |
| #9 | -10.65% Mar 19, 2015 - Jun 18, 2015 | -2.25% May 14, 2026 - May 26, 2026 |
| #10 | -10.08% Sep 12, 2005 - Nov 17, 2005 | -2.14% Dec 11, 2025 - Dec 23, 2025 |
| #11 | -9.07% Apr 25, 2007 - Sep 26, 2007 | -1.77% Jan 12, 2026 - Jan 22, 2026 |
| #12 | -8.60% Aug 29, 2014 - Oct 23, 2014 | -1.72% Sep 22, 2025 - Oct 1, 2025 |
| #13 | -7.84% May 28, 2013 - Jul 5, 2013 | -1.59% Feb 11, 2026 - Feb 20, 2026 |
| #14 | -7.21% Nov 29, 2013 - Jan 7, 2014 | -1.44% Apr 17, 2026 - Apr 24, 2026 |
| #15 | -6.59% Oct 2, 2013 - Oct 24, 2013 | -1.38% Jan 24, 2025 - Jan 30, 2025 |
Correlation
Correlation between PBE and AQLT is 0.92 which considered as a very strong positive correlation - the stocks move almost identically together.
0.92
-101
Dividend Comparison (2009 - 2026)
PBE vs AQLT dividend yield comparison.
| Year | PBE | AQLT |
|---|---|---|
| 2026 | 0.10% | 0.00% |
| 2025 | 1.00% | 1.05% |
| 2024 | 0.05% | 0.02% |
| 2023 | 0.02% | 0.00% |
| 2020 | 0.04% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.57% | 0.00% |
| 2016 | 0.38% | 0.00% |
| 2015 | 1.12% | 0.00% |
| 2014 | 0.55% | 0.00% |
| 2009 | 0.45% | 0.00% |
Select Stocks to Compare
Popular: PBE vs SPYAQLT vs SPY
More Comparisons
Compare with similar stocks